These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 37397696)
1. D-penicillamine-associated neutropenia in a Doberman pinscher. Brooks KV; Frederick SW; Berryessa NA Can Vet J; 2023 Jul; 64(7):639-642. PubMed ID: 37397696 [TBL] [Abstract][Full Text] [Related]
2. Improvement in liver pathology after 4 months of D-penicillamine in 5 doberman pinschers with subclinical hepatitis. Mandigers PJ; van den Ingh TS; Bode P; Rothuizen J J Vet Intern Med; 2005; 19(1):40-3. PubMed ID: 15715046 [TBL] [Abstract][Full Text] [Related]
3. Nutritional management of inherited copper-associated hepatitis in the Labrador retriever. Fieten H; Biourge VC; Watson AL; Leegwater PA; van den Ingh TS; Rothuizen J Vet J; 2014 Mar; 199(3):429-33. PubMed ID: 24439471 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and relative bioavailability of D-penicillamine in fasted and nonfasted dogs. Langlois DK; Lehner AF; Buchweitz JP; Ross DE; Johnson MB; Kruger JM; Bailie MB; Hauptman JG; Schall WD J Vet Intern Med; 2013; 27(5):1071-6. PubMed ID: 23875792 [TBL] [Abstract][Full Text] [Related]
5. Treatment of zinc toxicosis in a dog with chelation using d-penicillamine. Lee YR; Kang MH; Park HM J Vet Emerg Crit Care (San Antonio); 2016 Nov; 26(6):825-830. PubMed ID: 26587915 [TBL] [Abstract][Full Text] [Related]
6. Transient fetal myelosuppressive effect of D-penicillamine when used in pregnancy. Yalaz M; Aydogdu S; Ozgenc F; Akisu M; Kultursay N; Yagci RV Minerva Pediatr; 2003 Dec; 55(6):625-8. PubMed ID: 14676735 [TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of copper, zinc and iron with and without D-penicillamine administration in relation to hepatic copper concentration in dogs. Fieten H; Hugen S; van den Ingh TS; Hendriks WH; Vernooij JC; Bode P; Watson AL; Leegwater PA; Rothuizen J Vet J; 2013 Aug; 197(2):468-73. PubMed ID: 23583003 [TBL] [Abstract][Full Text] [Related]
8. Adverse effects of reduced-dose d-penicillamine in children with mild-to-moderate lead poisoning. Shannon MW; Townsend MK Ann Pharmacother; 2000 Jan; 34(1):15-8. PubMed ID: 10669180 [TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson's disease. Xu SQ; Li XF; Zhu HY; Liu Y; Fang F; Chen L J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):743-747. PubMed ID: 24142730 [TBL] [Abstract][Full Text] [Related]
10. Presumed primary immune-mediated neutropenia in 35 dogs: a retrospective study. Devine L; Armstrong PJ; Whittemore JC; Sharkey L; Bailiff N; Huang A; Rishniw M J Small Anim Pract; 2017 Jun; 58(6):307-313. PubMed ID: 28245056 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oral chelators in treatment of patients with Wilson disease. Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W; Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331 [TBL] [Abstract][Full Text] [Related]
12. D-penicillamine treatment of copper-associated hepatitis in Labrador retrievers. Fieten H; Dirksen K; van den Ingh TS; Winter EA; Watson AL; Leegwater PA; Rothuizen J Vet J; 2013 Jun; 196(3):522-7. PubMed ID: 23375251 [TBL] [Abstract][Full Text] [Related]
13. Copper-associated hepatitis in a Pembroke Welsh corgi. Rifkin J; Miller MD Can Vet J; 2014 Jun; 55(6):573-6. PubMed ID: 24891642 [TBL] [Abstract][Full Text] [Related]
14. Neutropenia and thrombocytopenia in three dogs treated with anticonvulsants. Jacobs G; Calvert C; Kaufman A J Am Vet Med Assoc; 1998 Mar; 212(5):681-4. PubMed ID: 9524640 [TBL] [Abstract][Full Text] [Related]
15. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial. Schilsky ML; Czlonkowska A; Zuin M; Cassiman D; Twardowschy C; Poujois A; Gondim FAA; Denk G; Cury RG; Ott P; Moore J; Ala A; D'Inca R; Couchonnal-Bedoya E; D'Hollander K; Dubois N; Kamlin COF; Weiss KH; Lancet Gastroenterol Hepatol; 2022 Dec; 7(12):1092-1102. PubMed ID: 36183738 [TBL] [Abstract][Full Text] [Related]
16. Biodynamic signatures from ex vivo bone marrow aspirates are associated with chemotherapy-induced neutropenia in cancer-bearing dogs. Marcum BA; Li Z; Turek JJ; Moore GE; Nolte DD; Childress MO Vet Med Sci; 2021 May; 7(3):665-673. PubMed ID: 33369129 [TBL] [Abstract][Full Text] [Related]
17. D-penicillamine-induced ANA (+) ANCA (+) vasculitis in pediatric patients with Wilson's disease. Lee Y; Lee ST; Cho H Clin Nephrol; 2016 May; 85(5):296-300. PubMed ID: 26784915 [TBL] [Abstract][Full Text] [Related]
18. Liquid chromatography/tandem mass spectrometric analysis of penicillamine for its pharmacokinetic evaluation in dogs. Lehner AF; Dirikolu L; Johnson M; Buchweitz JP; Langlois DK Toxicol Mech Methods; 2020 Nov; 30(9):687-702. PubMed ID: 32854553 [TBL] [Abstract][Full Text] [Related]
19. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease. Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346 [TBL] [Abstract][Full Text] [Related]
20. Neutropenia associated with vincristine and L-asparaginase induction chemotherapy for canine lymphoma. Northrup NC; Rassnick KM; Snyder LA; Stone MS; Kristal O; Cotter SM; Moore AS J Vet Intern Med; 2002; 16(5):570-5. PubMed ID: 12322708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]